TLDR: Germany’s national hospital digital maturity score climbed 65% since 2021, and the sector positioned to benefit most is life sciences, which now inherits an interoperable clinical data layer spread across more than 1,500 hospitals.
From 33.3 to 55.0 in five years
The average digital maturity score of German hospitals rose from 33.3 points in 2021 to 55.0 in 2026, a gain of 21.7 points or roughly 65% on a 100-point scale. Against the second survey’s 42.4 points, the latest round added a further 12.6 points, close to 30%. A total of 1,531 hospitals took part, and around 93.7% of the original cohort returned, which makes this one of the largest longitudinal hospital datasets anywhere. Every federal state improved, and smaller hospitals posted the steepest climbs, which narrowed the gap with larger centres.
| Assessment | Average DigitalRadar score (0–100) | |
|---|---|---|
| 2021 — first | 33.3 | |
| 2024 — second | 42.4 | |
| 2026 — third | 55.0 |
The programme runs on real money. The German Federal Ministry of Health commissioned the maturity instrument in 2021 to evaluate the Hospital Future Act (KHZG, Krankenhauszukunftsgesetz), a federal investment of up to 4.3 billion euros, with 3 billion from the federal government and 1.3 billion from the states and hospital operators. The score tracks where that capital landed.
Digital infrastructure and information exchange led the gains
The maturity measure spans dimensions that include digital infrastructure, information exchange, and clinical processes, and the 2026 round shows progress across all of them, with the strongest movement in those three areas. The pattern points to a next phase that shifts from building infrastructure to embedding digital capability in everyday clinical workflows. The translation for an outside reader is direct: German hospitals now capture, structure, and exchange clinical data at a level that earlier rounds treated as an aspiration.
Why a hospital maturity score lands on a pharma desk
Drug developers spend years and fortunes assembling clinical evidence, and the quality of that evidence depends on the systems that hold patient data. A hospital that scores well on information exchange runs interoperable electronic records, structured data, and the connective tissue that makes real-world evidence (RWE) usable. That same infrastructure shortens site activation, supports decentralized clinical trial (DCT) elements, and feeds post-market safety monitoring.
The market has been moving toward this model already. In September 2024 the United States Food and Drug Administration (FDA) issued final guidance on conducting clinical trials with decentralized elements, which formalised telehealth visits, local sample collection, and remote data capture as accepted trial methods. Those designs depend on the exact capabilities the maturity survey measures: remote data capture, interoperable records, and clinicians who work inside mature digital systems. A national lift in hospital maturity widens the pool of trial-ready and evidence-ready sites across one large market.
Germany already built the reimbursement rails
Germany pairs this infrastructure with a payment pathway that life sciences understands. The country pioneered the DiGA programme, the world’s first national system for prescribing reimbursed digital health applications, live since 2020. Statutory health insurers dispensed around 690,000 DiGA prescriptions in 2025 at a cost of roughly 171 million euros, which is the demand signal. The maturity data shows the supply side maturing underneath it. Read together, they describe a market where digital products reach patients through hospitals equipped to run them.
What life-sciences teams can act on this year
Medical affairs and RWE leads can map maturity performance against their German site networks and prioritise high-scoring hospitals for evidence generation and registry work. Clinical operations teams can shortlist mature centres for decentralized and hybrid trial designs, where interoperable records cut setup time. Market access teams can treat DiGA as a live route for digital companions to therapy, with the hospital data layer as the channel that carries adoption. Each move turns a public maturity score into a sourcing advantage.
The harder work sits where regulated data, clinical workflow, and commercial strategy meet, which is the terrain Kainjoo navigates with brands in health and life sciences. Germany has shown that national investment can move an entire hospital sector up the maturity curve. Companies that read the map early reach patients and evidence sooner, and the next national report will only confirm what the data already shows.
References
- Pressemitteilung zu den ersten Ergebnissen der dritten Erhebung (DigitalRadar Krankenhaus): https://www.digitalradar-krankenhaus.de/pressemitteilung-zu-den-ersten-ergebnissen-der-dritten-erhebung/
- Over EUR 4 billion for the digitalisation of hospitals, Future of Hospitals Act KHZG (Luther Rechtsanwaltsgesellschaft): https://www.luther-lawfirm.com/en/newsroom/blog/detail/over-eur-4-billion-for-the-digitalisation-of-hospitals-german-parliament-passes-future-of-hospitals-act-krankenhauszukunftsgesetz-khzg
- Digital Health Applications (DiGA), Interesting facts (BfArM): https://www.bfarm.de/EN/Medical-devices/Tasks/DiGA-and-DiPA/Digital-Health-Applications/Interesting-facts/_artikel.html
- DiGA-Bericht des GKV-Spitzenverbandes 2025 (GKV-Spitzenverband): https://www.gkv-spitzenverband.de/media/dokumente/krankenversicherung_1/telematik/digitales/2025_DiGA_Bericht_GKV_SV.pdf
- Conducting Clinical Trials With Decentralized Elements, final guidance, 18 September 2024 (US FDA, Federal Register): https://www.federalregister.gov/documents/2024/09/18/2024-21078/conducting-clinical-trials-with-decentralized-elements-guidance-for-industry-investigators-and-other
